The civic record
Read. Follow. Verify.New Jersey requires state licensure and reporting for pharmaceutical sales representatives
Last action · January 13, 2026: Introduced, Referred to Assembly Regulated Professions CommitteeSponsor: Auth, Robert
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
New Jersey requires sales representatives to obtain a state license from the State Board of Medical Examiners, complete annual continuing education, and periodically report all contacts, distributed gifts, and compensation.
sales representatives must pay license fees, complete mandatory training on opioids and marketing laws, and log every interaction with doctors, including any samples or payments provided.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Pharmaceutical representatives
Must obtain a state license, pay fees, complete mandatory continuing education, and submit periodic contact and gift reports to continue marketing in the state.
State Board of Medical Examiners
Assumes new duties to establish licensing criteria, review applications, approve continuing education courses, collect disclosure reports, and enforce professional standards.
Medical practitioners
Interactions with pharmaceutical representatives will be formally logged, and representatives are prohibited from attending patient examinations without patient consent.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Who is required to obtain a license under this bill?
What information must pharmaceutical representatives report to the state?
Who administers the licensing program?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
1 action- Jan 13, 2026HouseIntroducedIntroduced, Referred to Assembly Regulated Professions Committee
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
njleg.state.nj.us
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy45Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools